Laser-assisted capsulotomy results better than CCC

Article

Femtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy.

Femtosecond laser-assisted capsulotomy resulted in better circularity and more predictable size compared with standard manual continuous curvilinear capsulorhexis (CCC) in a prospective, randomized clinical study by researchers in Italy. They also found that IOL centration was better immediately following surgery and over time for patients who underwent femtosecond laser-assisted capsulotomy. The results are published in the Journal of Cataract & Refractive Surgery.

Candidates for cataract extraction were randomly assigned into 1 of 3 groups, each with 30 eyes of 30 patients:

  • Laser group 1 underwent femtosecond laser–assisted cataract surgery capsulotomy performed with a proprietary laser (LenSx, Alcon),

  • Laser group 2 had femtosecond laser–assisted cataract surgery capsulotomy performed with a proprietary laser (Lensar Laser System, Lensar Inc.), and

  • The manual group underwent manual CCC.

After 7 days, the capsulotomies in both laser groups showed significantly better circularity than did those the CCCs of the manual group. The two laser groups also showed a significant correlation between the intended versus achieved capsulotomy size as well as better IOL centration than the manual group at all timepoints.

Distance visual acuity, both corrected and uncorrected, was not different in a statistically significant way between groups. Residual spherical equivalent and mean absolute error, however, were statistically significantly smaller in the laser groups than in the manual group, and they increased significantly over time in all the groups.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.